The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...
Going for a regular eye check-up is about more than assessing your ability to see. Your eyes can be a window to early ...
The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.
No changes in protocol recommended for LUGANO and LUCIA clinical trials –– Masked safety data continues to show no safety signals, consistent ...
The FDA also approved an every 4 week dosing regimen across all approved indications for patients who may not maintain a response on extended dosing intervals following successful initial treatment.
The inverted ILM flap technique yields better macular hole closure than ILM peeling for some high myopic macular holes.
Pickleball-related ocular injuries are significantly up, inspiring research presented at a recent ophthalmology conference.
AAO 2025 revealed that true-color widefield imaging, AI-powered home OCT, and refined FAERS analyses are collectively transforming retinal diagnostics into a more precise, continuous, and safety-aware ...
Panelists discuss how key biologic and clinical distinctions—such as ischemia, leakage patterns, and modality-specific ...
A new study in mice shows that briefly anesthetizing the retina of the weaker eye can restore its neural influence in the adult visual cortex.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback